Weight loss treatment for covid-19 in patients with ncds: a pilot prospective clinical trial

HIGHLIGHTS

• What: The aim of this study was to evaluate the effects of a restricted diet on clinical and laboratory inflammation, metabolic profile, reactive oxygen species (ROS), and body composition in patients with COVID-19 comorbid with T2D/hypertension/NASH. | Vol:.(1234567890) 14:10979 | Study design and participants The main reason for inclusion of patients in Main group was that the majority of patients refused pharmacology therapy either due to previous unsuccessful drug results, antimicrobial resistance profile, drug allergies, or because of the risk of developing severe symptoms of NASH. This study demonstrated the beneficial effects of weight . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.